Literature DB >> 27144623

Multicultural Aspects in Functional Gastrointestinal Disorders (FGIDs).

Xiucai Fang1, Carlos F Francisconi2, Shin Fukudo3, Mary-Joan Gerson4, Jin-Yong Kang5, Max J Schmulson W6, Ami D Sperber7.   

Abstract

Cross-cultural factors are important in functional gastrointestinal disorders (FGIDs). In the setting of FGIDs, the aims of this review were to: 1) engender interest in global aspects; 2) gain a clearer understanding of culture, race and ethnicity and their effect on patient care and research; 3) facilitate cross-cultural clinical and research competency; and 4) improve and foster the quality and conduct of cross-cultural, multinational research. Cultural variables are inevitably present in the physician-patient context. Food and diets, which differ among cultural groups, are perceived globally as related to or blamed for symptoms. From an individual perspective, biological aspects, such as genetics, the microbiome, environmental hygiene, cytokines and the nervous system, which are affected by cultural differences, are all relevant. Of equal importance are issues related to gender, symptom reporting and interpretation, and family systems. From the physician's viewpoint, understanding the patient's explanatory model of illness, especially in a cultural context, affects patient care and patient education in a multicultural environment. Differences in the definition and use of Complementary and Alternative Medicine and other issues related to healthcare services for the FGIDs are also a relevant cross-cultural issue. This paper highlights the importance of cross-cultural competence in clinical medicine and research.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Culture; cross-cultural competence; cross-cultural factors; cross-cultural research; explanatory model; food and food taboos; symptom interpretation

Year:  2016        PMID: 27144623     DOI: 10.1053/j.gastro.2016.02.013

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Diversity Within US Gastroenterology Physician Practices: The Pipeline, Cultural Competencies, and Gastroenterology Societies Approaches.

Authors:  John M Carethers; Sandra M Quezada; Rotonya M Carr; Lukejohn W Day
Journal:  Gastroenterology       Date:  2018-11-17       Impact factor: 22.682

Review 2.  The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.

Authors:  Changhyun Lee; Eunyoung Doo; Ji Min Choi; Seung-Ho Jang; Han-Seung Ryu; Ju Yup Lee; Jung Hwan Oh; Jung Ho Park; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

Review 3.  Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519

Review 4.  What Is New in Rome IV.

Authors:  Max J Schmulson; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

5.  The Digestive Health among Participants of the Woodstock Rock Festival in Poland-A Cross-Sectional Survey.

Authors:  Karolina Skonieczna-Żydecka; Ewa Stachowska; Dominika Maciejewska; Karina Ryterska; Joanna Palma; Maja Czerwińska-Rogowska; Mariusz Kaczmarczyk; Anna Gudan; Honorata Mruk; Barbara Świniarska; Justyna Kałduńska; Zofia Stachowska; Przemysław Mijal; Tomasz Mazur; Maciej Kupczyński; Wojciech Marlicz
Journal:  Int J Environ Res Public Health       Date:  2018-10-15       Impact factor: 3.390

Review 6.  Cultural Factors Influencing Functional Gastrointestinal Disorders in the East.

Authors:  Kee-Huat Chuah; Sanjiv Mahadeva
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

7.  Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.

Authors:  Masanori Kosako; Hiraku Akiho; Hiroto Miwa; Motoyori Kanazawa; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2018-12-05

Review 8.  Ethnic differences in genetic polymorphism associated with irritable bowel syndrome.

Authors:  Qi-Yun Xiao; Xiu-Cai Fang; Xiao-Qing Li; Gui-Jun Fei
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

9.  Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome?

Authors:  Seung-Ho Jang; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

10.  High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan.

Authors:  Shin Fukudo; Hiroto Miwa; Atsushi Nakajima; Yoshikazu Kinoshita; Masanori Kosako; Kenta Hayashi; Hiraku Akiho; Kentaro Kuroishi; Jeffrey M Johnston; Mark Currie; Toshifumi Ohkusa
Journal:  Neurogastroenterol Motil       Date:  2018-10-23       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.